Cyproheptadine in Schizophrenia
Phase 3
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20100127003210N22
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Ages 18-65 years
Diagnosis of schizophrenia or schizoaffective disorder (Deppresive type) based on DSM-V
Taking Risperidone as an Antipsychotic
Fill in the consent
Exclusion Criteria
Antipsychotic treatment other than Risperidone
History of non-response to second generation antipsychotic treatment
Drug abuse
Thyroid Disorder
Pregnancy and Lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive and Negative Syndrome. Timepoint: At the beginning of the study, the first week, the second week, the fourth week, the sixth week. Method of measurement: PANSS Questionnaire.
- Secondary Outcome Measures
Name Time Method